The of and reducing our the please Kevin, MC Thanks, us I'll the Slide did highlighting volatile, optimization portfolio XX. Ashland remarkable start team turn return stable and nearing our to a for businesses, We to end low by CMC that positioning job and journey. we're Pharmachem, exposure more profitable growth.
By XXX Our complete. ourselves our basis future expansion we program, and points finalize will to actions should XXX transformation business deliver of margin and growth. the for Avoca our restructuring strategic selling implementing position fully million when $XX
to turn Slide XX. Please
priorities. financial Strategy our to globalized, month, strategic execute, and continue priorities the our our road outlined Our serve as innovate to guide and a map actions. At Update best last aligned clear with we commitments
on these and demonstrate some While efforts transparent these believe time initiatives. of important will progress take commitment updates regular will our we
Please turn to Slide XX.
focuses the will controllable factors which execute, with drive near-term start that performance. Let's on
Avoca. agreement Pharmachem signed Avoca signing, that Nutraceuticals fully to recognize we in our in repurchased unwinding the to was item key a is exiting step we mentioned, EPS acquisition. with divest This profile a will of impairment ongoing business the the of improving the and quarter. financial from noncash the recently business. exit last line, noncore and In key the impact neutralize QX We a year in a As shares connection the
now EBITDA offsetting focusing the are We on impact.
delivering $XX cost target. our saving is priority highest The million on
First, our million restructuring. $XX
and million Our $XX achieved. of million already rate with opportunities run $XX efforts are well annual identified underway
savings upcoming will months. continue We generating further are the momentum it, in restructuring confident this
million the is $XX optimization. of manufacturing Second
HEC is focus on Initial on strengthening been reminder, As VP&D. and with manufacturing later. of majority the of consolidation has improvements coming the productivity activities process focus a
Ashland through XXXX. manufacturing those fiscal on fiscal flow-through will City have savings rate in at City. already from we track the be million include timing annual year and have be of Texas generated on operations will initiatives Calvert some least taken data. a to $XX [ Overall, to our we we're in improvement. EBITDA the more $XX of initiatives ] There's element million productivity as Executed XXXX consolidation plant communicating achieving of run
ambitious targets This Slide assets, Each revenue Please Strategy fiscal revenue trajectory turn At growth. aiming achievable to and Starting introduced $XXX additional for in expectations to XXXX. fiscal people slide accelerate our technology yet highlights generate innovate globalize, and XXXX. for to million are in our XX. initiatives. by investing Day, globalized the growth near-term we and we with
targets by revenue to years. translate growing Our roughly few the over them XX% next
a that While injectables. track -- $XX historic largest and offsetting slow fiscal [ our in strong in confident these a goal their Microbio given confident start our had the ], given is business achieve start We to partially strong to strategic team globalized higher lines lines business business year, of Protection XXXX record. these The progress remain million sales.
is impactful and to most trajectory. move long-term strategy, growth let's incremental XXXX our significantly by our This Now innovation. predicted enhance generate $XXX in long-term sales million to initiative
growth innovation in incremental $XX While fiscal sales time, takes and we're million targeting XXXX. in
last As about is the innovation. heard incredibly enthusiastic you month, team
in to aspirations share XXXX the Our by sales robust in calendar plans in supported bring the X likely during update last line platform are $X details will ambitious upcoming months, a meantime, chemistry new up million with game-changing year to this at from quarter. and innovation launch progress life. growth an introductions, which product host with XXXX plan, I'll the In more year. incremental is our X includes
XX. to turn Slide please let's Now
for fiscal Now let's XXXX. to our turn outlook
we Europe and our and policy adopting committed While on delivering we to transitions, face are uncertainty commitments. China, in and a dynamic landscape global
policy of and impact clarity provide transition the factors. course, Of macroeconomic the coming will months more on other
press adjusted EBITDA Several outlook. we our full factors this. and affirming yesterday, sales in our are are key supporting noted release As year
in it contemplated weakness full already quarter, much of year the guidance. of pockets saw we was our in While
As Chinese competition anticipated, pricing, impacting exports expectations. largely increased line with but is from in
largely recent the the the been past It's expected the to strengthened mixed, adjustment overall X but dollar over mentioned, has the markets, Alessandra inventory raw QX As pharma remain customer is watching considerably We're dynamic. environment also FX is stable. by a material months.
$XXX million Our a provides it Eurobond our impacts but still partial hedge, EBITDA.
the million initiatives selling lastly growth strategic initiatives second, in quarter; the catalyst Avoca business threefold: and momentum our XXXX year, for least restructuring this building and our maintain first, at productivity this trajectory is $XX we accelerating and future. to focus of that for savings achieve Lastly, our the for
to sales to the and $X.X in For billion of year, to the continue in we EBITDA expect fiscal $XXX range million. range adjusted million full $XXX billion $X.XX of the
turn Please In the to from Slide takeaways I XX. want key closing, restate today. to
generally accelerating X divestiture we line Our manufacturing was another maintaining transformation. be excellence and our Fiscal the including agreement savings to year advancing of portfolio delivering operational business Day. facilities high-quality in Avoca shared expected signing technology pricing choppy market, initiatives, approach and the globalizing for a milestone managing in first we cost first ensuring disciplined are lines, year XXXX is million across allocation. of focused balanced platforms, expectations performance market business, with and Ashland's our and the share, capital the $XX our Strategy quarter at The new in commercialization a marks our to maintaining on
flexibility long-term growth of profitability committed today. XXXX have business. the confident challenges strong our in -- in our and long-term sheet goals growth to potential to invest of the We and catalysts our fiscal remain balance proactively to healthy addressing while continue provide the Our we us remain
Q&A. proactive environment. want leadership a to go Ashland thank of to their dynamic and once again I let's businesses in for the Operator, team their ownership
